SCHEMBL19943717

SCHEMBL19943717

N=C/C=C\Nc1ccncc1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AOC1 P19801 2/20 0.35
▸ AOC3 Q16853 2/20 0.35
▸ ALDH1A1 P00352 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ GAA P10253 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KDM6B O15054 1/20 0.33
▸ KDM4A O75164 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ KDM4D Q6B0I6 1/20 0.33
▸ KDM4C Q9H3R0 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ IMPDH2 P12268 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ CA12 O43570 1/20 0.31
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28162233 0.74 ALDH1A1 (0.41) AOC1AOC3ALDH1A1KDM4EGAA
SCHEMBL13624973 0.71 GAA (0.33) ALDH1A1GAAMAPTTDP1
SCHEMBL9330010 0.69 — —
SCHEMBL30074192 0.67 — —
SCHEMBL2046959 0.67 — —
Hydrochloric Acid SCHEMBL27703391 0.66 AOC1 (0.53) AOC1AOC3ALDH1A1KDM4EGAA
SCHEMBL14003573 0.64 RAD52 (0.52) AOC1AOC3ALDH1A1KDM4EGAA
SCHEMBL8271734 0.63 — —
SCHEMBL5027429 0.63 PTGS1 (0.35) KDM4EMAPTMEN1KMT2AKDM4C
SCHEMBL18857496 0.63 CA12 (0.46) AOC1AOC3ALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4190786-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Vertex Pharmaceuticals Incorporated (US) 2023-06-07 — — EP disclosed
EP-3808749-A1 PYRAZOLO[1,5-A]PYRIMIDINES USEFUL AS INHIBITORS OF ATR KINASE FOR THE TREATMENT OF CANCER DISEASES Vertex Pharmaceuticals Incorporated (US) 2021-04-21 — — EP disclosed
EP-3418281-B1 PYRAZOLO[1,5-A]PYRIMIDINES USEFUL AS INHIBITORS OF ATR KINASE FOR THE TREATMENT OF CANCER DISEASES VERTEX PHARMA (US) 2020-09-30 — — EP disclosed
EP-3486245-A1 2-AMINO-N-(PIPERIDIN-1-YL-PYRIDIN-3-YL) PYRAZOLO[1,5ALPHA]PYRIMIDINE-3-CARBOXAMID AS INHIBITOR OF ATR KINASE Vertex Pharmaceuticals Incorporated (US) 2019-05-22 — — EP disclosed
EP-2941432-B1 2-AMINO-6-FLUORO-N-(5-FLUORO-4-(4-(4-(OXETAN-3-YL)PIPERAZINE-1-CARBONYL)PIPERIDIN-1-YL)PYRIDIN-3-YL)PYRAZOLO[1,5ALPHA]PYRIMIDINE-3-CARBOXAMIDE AS INHIBITOR OF ATR KINASE VERTEX PHARMA (US) 2018-03-07 — — EP disclosed
Send feedback